TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/24 16:22 | 8/21/24 | TRML | Tourmaline Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kulkarni Sandeep Chidambar | NY | DO | CEO | P | 26 | 14.85 | 0 | 2 | 34 | 7 | I | ||||||||||||||
8/20/24 18:09 | 8/16/24 | TRML | Tourmaline Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kulkarni Sandeep Chidambar | NY | DO | CEO | P | 72 | 13.79 | 0 | 5 | New | 5 | I | ||||||||||||||
11/20/23 18:15 | 11/17/23 | TRML | Tourmaline Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kulkarni Sandeep Chidambar | NY | DO | CEO | P | 68 | 16.99 | 0 | 4 | 1 | 730 | D | ||||||||||||||
10/26/23 17:34 | 10/24/23 | TRML | Tourmaline Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kulkarni Sandeep Chidambar | NY | DO | CEO | P.m | 111 | 11.49 | 0 | 10 | 1 | 726 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |